Canagliflozin, a novel inhibitor of sodium glucose co-transporter 2, dose dependently reduces calculated renal threshold for glucose excretion and increases urinary glucose excretion in healthy subjects (Q83764954)
Jump to navigation
Jump to search
scientific article published on 01 July 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Canagliflozin, a novel inhibitor of sodium glucose co-transporter 2, dose dependently reduces calculated renal threshold for glucose excretion and increases urinary glucose excretion in healthy subjects |
scientific article published on 01 July 2011 |
Statements
Canagliflozin, a novel inhibitor of sodium glucose co-transporter 2, dose dependently reduces calculated renal threshold for glucose excretion and increases urinary glucose excretion in healthy subjects (English)
S Sha
D Devineni
A Ghosh
D Polidori
S Chien
D Wexler
K Shalayda
K Demarest